This list is an analysis based on recent market events. It's not an investment recommendation.
Neurophet Inc. is a neuroscience company focused on developing cutting-edge medical artificial intelligence solutions for the study and treatment of brain conditions. Its array of offerings includes Neurophet AQUA, an AI-powered diagnostic aid for identifying brain diseases, and Neurophet SCALE PET, software for precisely analyzing biomarkers detected by specific radiotracers in PET imaging. The firm also provides Neurophet tES LAB, an AI-driven platform that generates 3D brain models from MRI scans to simulate electrical stimulation for therapeutic planning. Additionally, Neurophet produces Neurophet innk, a non-invasive electrical stimulation device designed to support functional recovery and rehabilitation for individuals with neurological disorders. Complementing these products, Neurophet offers consulting services for design and quality management systems. This company was established in 2016 and is headquartered in Seoul, South Korea.
FAQs
What is NEUROPHET stock price today?▼
The current price of 380550.KQ is ₩5,340 KRW — it has decreased by -4.81% in the past 24 hours. Watch NEUROPHET stock price performance more closely on the chart.
What is NEUROPHET stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange NEUROPHET stocks are traded under the ticker 380550.KQ.
Is NEUROPHET stock price growing?▼
380550.KQ stock has fallen by -12.94% compared to the previous week, the month change is a -31.53% fall, over the last year NEUROPHET has showed a -78.29% decrease.
When is the next NEUROPHET earnings date?▼
NEUROPHET is going to release the next earnings report on November 13, 2026.
How many employees does NEUROPHET have?▼
As of November 4, 2026, the company has 35 employees.
In which sector is NEUROPHET located?▼
NEUROPHET operates in the Health & Wellness sector.
When did NEUROPHET complete a stock split?▼
NEUROPHET has not had any recent stock splits.
Where is NEUROPHET headquartered?▼
NEUROPHET is headquartered in Seoul, South Korea.